The Europe gout therapeutics market, valued at USD 688.26 million in 2024, is anticipated to expand at a CAGR of 6.8% from 2025 to 2034, with growth increasingly driven by segment-wise performance across product types, treatment phases, and therapeutic platforms. The market can be segmented by product type into urate-lowering therapies (ULTs), anti-inflammatory agents, and emerging...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek